Nationalität
USA
Geburtsjahr
1977
1999
Mikrobiologie an der Miami University in Oxford, Ohio, B.A.
2006
Business Administration an der University of California, San Diego, Kalifornien, MBA
2002–2008
Roche Diagnostics, USA, Verschiedene Account / Produkt Manager Rollen
2008–2010
Japan / APAC, Tokio, Commercial Operations Manager
2010–2012
Taiwan, Taipei City, Director Applied Science / Director Molecular Diagnostics
2012–2014
Roche Diagnostics Irland, Dublin, Country Manager
2014–2016
Roche Pharma Peru, Lima, President / General Manager
2016–2018
Roche Pharma Korea, Seoul, President / General Manager
2018–2019
Genentech, USA, Vice President, Lifecycle Leader für Tecentriq Lungen-, Kopf- und Halskrebs
2019
Foster City, USA, Senior Vice-President, Head of Global Commercial Product Strategy, Gilead Sciences
2019–2022
Roche Diagnostics Corporation North America, Indianapolis, USA, President & CEO
Seit 2023
Roche Diagnostics Basel, CEO, Mitglied der Konzernleitung
–
–
Seit 2019
AdvaMed, Mitglied des Verwaltungsrats
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.